New York, NY (PressExposure) February 25, 2013 -- Synowledge, a market leader known for its global and progressive approach to providing drug safety, regulatory affairs and related IT solutions to life sciences organizations, is pleased to announce that it will exhibit at the 25th Annual Drug Information Association (DIA) EuroMeeting in Amsterdam, Netherlands on March 4-6th, 2013. Synowledge will showcase its range of proven, industry-leading drug safety and regulatory affairs solutions at booth number 119.
The DIA is the premier global professional association for the biopharmaceutical industry, comprised of nearly 18,000 members. The EuroMeeting is the DIA's flagship annual meeting in Europe, attracting more than 3,000 professionals from over 50 countries. It brings together professionals from the biopharmaceutical industry, contract service organizations, clinical research, regulatory agencies, health ministries, patients' organizations and universities.
Synowledge will be exhibiting throughout the three days of the conference and attendees are invited to visit Synowledge at booth 119 to learn more about our extensive suite of drug safety and regulatory affairs solutions.
Event: 25th Annual DIA EuroMeeting
Date: March 4-6th, 2013
Location: RAI, Amsterdam, Netherlands
Booth: 119, for floor plan please visit: http://www.synowledge.com/synowledge-booth.html
For more information about the DIA 25th Annual EuroMeeting, please visit: http://www.diahome.org/en-US/Flagship-Meetings/13101-EuroMeeting.aspx
Founded in 2006, Synowledge specializes in providing drug safety, regulatory affairs and related IT services to small, mid, and large sized pharmaceutical, biotechnology and medical device companies. Our comprehensive outsourcing solutions combine the unique strengths of both onshore and offshore services to meet our clients' needs. Synowledge is headquartered in Stamford, CT, USA with operation facilities located in Ohio, the United Kingdom, Germany and Bangalore, India. Synowledge's broad range of solutions and KPO services include full case management (incl. case intake, data entry, coding, triaging, QC, medical review, submission, etc.), generation of expedited and periodic reports, Qualified Person for Pharmacovigilance (QPPV) services, medical literature review, analysis and trending of cases (signal detection), and a call center services that handles medical inquiries/information, AE/SAE case intake and product complaints.